New restrictions are increasingly squeezing international researchers in the US and threatening the country’s long-term ...

In this Eye on Patents column, IP expert Jason Lye explains how China became the global leader in chemistry patents ...

Merck & Co. scientists use a suite of enzymes to manufacture the cholesterol-lowering drug candidate enlicitide ...

The Environmental Protection Agency is dropping its Integrated Risk Information System, according to a leaked internal memo, ...

Chemical makers express relief after concerns over competitiveness put a stop to the EU’s overhaul of its flagship chemical ...

A repurposed reagent can stereoselectively insert nitrogen into C–H bonds, even those unactivated by nearby functional groups ...

This Greening Chemistry column explores how to find savings in the lab and the false economy of buying supplies on sale ...

Attacks on fuel facilities, military bases, and industrial sites release pollutants that might harm long after the war is ...

Today’s challenges only reinforce Barry Commoner’s call at a 1973 ACS regional meeting to redesign the sector “to accord with ...

These episodes of exhaustion were sometimes so severe that she needed to be hospitalized and receive pain medication and blood transfusions. When she was about 5 years old, the doctors figured out why ...

The justices’ questions reflected the blurred political lines around pesticides and the EPA’s power to regulate them ...

Meanwhile, peroxisome proliferation-activated receptors (PPARs) are obesity drug targets in their own right: activating them can reduce inflammation and restore insulin sensitivity. But molecules that ...